Industrial Water Processes and Pharmaceutical Microbiology

Definition and Scope of Industrial Process Water

Process water is defined as any water being processed for use within a manufacturing plant, specifically intended for the production of pharmaceutical products and medical devices. It serves multiple critical roles within the industrial environment, acting as a primary raw material, a sanitization agent, and a fundamental component in the preparation of culture media. Furthermore, it is utilized as a manufacturing tool and as a physical means to remove endotoxins throughout various production stages.

Patient Risk Assessment and Product Hierarchy

The potential risk to patient safety is heavily dependent on the route of administration of the pharmaceutical product containing or manufactured with the water. The risk hierarchy is categorized as follows, from highest to lowest risk: 1) Parenterals and implantable devices; 2) Sterile aerosols and inhaled powders; 3) Nasal sprays; 4) Ophthalmic products; 5) Vaginal suppositories, ointments, and creams; 6) Topical lotions, gels, ointments, transdermal patches, and creams; 7) Aqueous oral liquids; 8) Non-aqueous oral liquids; 9) Rectal suppositories, ointments, and creams; 10) Liquid-filled capsules; and 11) Oral tablets and powder-filled capsules.

Potable Water Standards and Limitations

Potable water, often sourced from public aqueducts, is the baseline for manufacturing facilities. It is utilized primarily for cleaning general areas and preparing house-disinfectants. In Costa Rica, its consumption and quality are regulated by the Ministry of Health, while in the United States, the EPA sets the standards. However, potable water is strictly prohibited for use in manufacturing processes or within cleanrooms because it can negatively impact controlled environments.

Potable water typically carries a relatively high load of microorganisms, some of which may exhibit resistance to the chlorine used for disinfection. A critical caveat is that chlorine inactivates over time; if the residual chlorine levels are lost during storage, a significant growth of Gram-negative bacteria can occur. Therefore, if potable water is stored, it requires rigorous additional controls to prevent microbial proliferation.

Purified Water (USP) and Highly Purified Water (EU)

Purified Water, as defined by the USP (United States Pharmacopeia), must be produced from a source of potable water at minimum. It is utilized for oral administration products, fermentation processes, culture media preparation, and as a solvent for detergents and disinfectants used in ISO Class 8 (EU Class C) cleanrooms. It is also common for autoclaves and medical implants. Microbiologically, it must contain $\le 100\,UFC/mL$. Physico-chemically, it must meet USP 643 for Total Organic Carbon (TOC) and USP 645 for conductivity, maintaining a pH between $5$ and $7$, with minimal concentrations of ions and metals. This water is typically produced via reverse osmosis.

Highly Purified Water (WHP) is a standard specific to the European Pharmacopeia (EU PH) and does not exist in the USP. It is required for medications needing high microbial quality where pyrogen presence is not critical, such as ophthalmic, nasal, otic, and cutaneous preparations. Its microbiological limit is $\le 10\,UFC/100mL$, and bacterial endotoxins must be $\le 0.25\,EU/mL$. Physico-chemically, it must be cleaner than standard purified water.

Water for Injection (WFI)

Water for Injection (WFI) represents the highest quality of pharmaceutical water, as its quality is critical for products injected directly into the body. It is used for manufacturing sterile products, reconstitution of lyophilized powders, and parenteral solutions. It also serves for cleaning and disinfectant preparation in ISO Class 7 or cleaner (EU Class B or cleaner) environments.

According to European Pharmacopeia guidelines, WFI must be prepared using distillation as the primary method. The potable water used as the feed source for WFI production must not exceed $259\,EU/mL$ of endotoxins. The final WFI product must adhere to a microbial limit of $\le 10\,UFC/100mL$ and an endotoxin limit of $\le 0.25\,EU/mL$.

Water Treatment Infrastructure and Pre-treatment Stages

A typical treatment system, such as a continuous reverse osmosis system with deionization (RO/CDI/UF), involves several protective stages. The process begins with public drinking water passing through a Multi-media Filter, also known as deep filtration, which removes solid particles between $7\text{--}10\,\mu m$ to prevent downstream damage.

Following this, Activated Carbon units are used to remove organic material, low-molecular-weight oxidants, chlorine, and chloramines through adsorption. This stage is vital for protecting downstream membranes and resins, though the carbon itself is highly susceptible to microbial growth. Subsequently, Dual Softeners utilize sodium-based ion exchange resins to remove water hardness (magnesium and calcium) and ammonium released by chloramines, which protects reverse osmosis and distillation units.

Core Purification Technologies: DI, RO, and Ultrafiltration

The Deionization (DI) system removes cations and anions using charged resins. Using an anode and a cathode, the system attracts ions to their respective opposite charges. Anionic resins specifically help in removing negatively charged endotoxins. This system requires periodic regeneration with acids and bases and is susceptible to microbial colonization.

Reverse Osmosis (RO) utilizes semi-permeable membranes to provide chemical, microbial, and endotoxin purification, typically achieving a 1 to 2 log reduction of most impurities. However, RO membranes are extremely sensitive to the sanitization process. Ultrafiltration (UF) serves as a final purification step to remove endotoxins, using a molecular weight cut-off of $10,000$ to $20,000\,Daltons$. While effective, UF performance depends heavily on the efficiency of the pre-treatment stages.

Distillation, UV, and Ozone Sanitization

Distillation achieves purification via vaporization and condensation, leaving behind non-volatile substances. It is the preferred method for WFI in the EU, offering a 3 to 4 log reduction in contaminants, though it does not provide absolute removal of all ions if vapor droplets carry them over.

Post-treatment destruction and prevention of microorganisms often involve UV light and Ozone. UV light at $189\,nm$ acts as a bactericidal barrier and reduces TOC, while UV light at $254\,nm$ is used to destroy residual ozone to prevent damage to RO membranes. Ozone ($O_3$) is a powerful oxidizing agent and effective sporicide generated by high-voltage discharge ($6\text{--}20\,kV$). It works by rupturing the external membranes of microorganisms and oxidizing DNA and RNA. Industrial protocols suggest maintaining an ozone residual of $0.3\text{--}1\,mg/mL$ for $2\,hours$ or $4\text{--}5\,mg/mL$ for $15\text{--}20\,minutes$. To neutralize ozone after use, a $354\,nm$ UV lamp (though also cited as 254 nm in different contexts) is used to convert it back to $O_2$.

Storage and Distribution Systems

Purified water is stored in stainless steel tanks with sanitary finishes to ensure a steady supply and allow for system maintenance. These tanks feature hydrophobic air filters and burst discs to allow gas exchange while preventing microbial entry. Sanitization of the tanks is often achieved using a spray ball system. In distribution, the water must be kept in constant circulation through a hygienic pump to prevent stagnation.

Microbiological Monitoring and Biofilm Formation

The microbiota of water systems is primarily composed of Gram-negative bacteria such as Hyphomicrobium, Caulobacter, Gallionella, and Pseudomonas species. Monitoring is performed using aseptic sampling and incubation on either Standard Count Agar or Reasoner's 2A (R2A) agar. R2A is preferred for recovering aquatic bacteria that are physiologically adapted to nutrient-poor environments; however, this requires long incubation periods of $10\text{--}14\,days$ at $30\text{--}35\,^{\circ}C$.

Biofilms are a significant threat, defined as bacterial populations firmly attached to surfaces and encased in a sticky polysaccharide matrix. This matrix captures nutrients and protects the bacteria, providing up to $500\,times$ more resistance against biocides than planktonic cells. To prevent biofilms, systems should use high-velocity water flow, smooth surfaces, frequent sanitization, and the elimination of dead-legs (stagnant areas).

Pathogens and Regulatory Comparison

Specific microorganisms of concern include the Burkholderia cepacia complex, which is analyzed using selective media where positive colonies appear green/brown with a yellow halo. Additionally, Ralstonia species (R. mannitolilytica and R. pickettii) are identified as emerging pathogens in pharmaceutical water systems.

Comparative standards between the EU PH and USP highlight specific thresholds for Bulk Purified Water (PW) and WFI. For instance, both standards generally require conductivity of $\le 1.3\,\mu S/cm$ at $25\,^{\circ}C$ for WFI, and TOC levels $\le 500\,ppb$. The total viable aerobic count for WFI is capped at $< 10\,cfu/100mL$ in both jurisdictions. TOC is calculated as the difference between Total Carbon (TC) and Inorganic Carbon (IC) ($TOC = TC - IC$). Endotoxin levels are measured using the Limulus Amebocyte Lysate (LAL) methodology, with a standard limit of $0.25\,EU/mL$.

Questions & Discussion

The presentation concluded with an open floor for questions from the audience regarding the industrial processes and microbiological controls discussed by Dr. Eduardo Gutiérrez.